在2型糖尿病中探索甲胺单疗反应:通过使用机器学习算法的临床,基因组和蛋白质组标记器进行计算洞察
Angelina Thomas Villikudathil1, Declan H Mc Guigan1, Andrew English2
1Ulster University, Centre for Stratified Medicine, Faculty of Life and Health Sciences, Magee Campus, Londonderry, Northern Ireland, United Kingdom.
Computers in biology and medicine
|February 18, 2024
概括
这项研究确定了临床,基因组和蛋白质组生物标志物,以预测2型糖尿病患者对甲福明的反应. 一个机器学习模型在早期识别非响应者方面取得了83%的准确性.
科学领域:
- 生物医学科学 生物医学科学
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
- 机器学习 机器学习
背景情况:
- 2型糖尿病 (T2DM) 影响着数百万人,其中甲胺作为主要治疗方法.
- 很大一部分T2DM患者 (35%) 没有对甲福林的有效反应.
- 不有效的甲福林治疗导致与糖尿病相关的并发症和大量的医疗保健费用.
研究的目的:
- 通过综合临床,基因组和蛋白质组数据,研究甲福林在T2DM中的疗效.
- 发现用于预测T2DM患者早期甲胺反应的新生物标志物.
- 开发一种机器学习模型,用于早期识别不响应甲素的患者.
主要方法:
- 来自T2DM患者Diastrat队列的临床,基因组和蛋白质组数据的分析.
- 识别显著的遗传变异 (例如,LPHN3,TRPC6),区分响应者和不响应者.
- 蛋白质组分析以确定关键标记物 (例如,HAOX1,CCL17,PAI) 和机器学习模型的开发.
主要成果:
- 肌素水平和体重与甲胺反应有负相关性.
- 特定的基因变异 (rs6551649,rs6551654,rs4495065在LPHN3;rs7940817在TRPC6) 与反应有关.
- 确定了15个重要的蛋白质标记物,其中HAOX1,CCL17和PAI显示出显著的折叠变化.
- 一个机器学习模型以83%的准确度预测了非响应者.
结论:
- 该研究确定了T2DM中甲福林反应的潜在临床,基因组和蛋白质组预测因素.
- 一个机器学习模型显示,对早期检测不响应者的结果非常有希望.
- 为了确定临床实用性,需要对潜在队列进行进一步的验证.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects
172
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
172


